Ting Wang

Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics

M. Carducci, D. Armstrong, C. Collins, 2012, Investigational New Drugs.

TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.

David C. Smith, N. Agarwal, G. Sonpavde, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updated analyses for RESTORE cohort C: A trial of bipolar androgen therapy for patients with newly castration-resistant prostate cancer.

Hao Wang, E. Antonarakis, S. Denmeade, 2022, European journal of cancer.

A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer

P. Febbo, A. Jimeno, A. Partin, 2010, Clinical Cancer Research.

TRANSFORMER: Bipolar androgen therapy (BAT) versus enzalutamide (E) for castration-resistant metastatic prostate cancer (mCRPC).

David C. Smith, N. Agarwal, E. Antonarakis, 2020 .

Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials

Nicole Senft, E. Heath, T. Albrecht, 2017, BMC Cancer.

The safety of combining immune checkpoint inhibitors and platinum-based chemotherapy for the treatment of solid tumors: A systematic review and network meta-analysis

Y. Gong, T. Mei, Ting Wang, 2023, Frontiers in Immunology.

Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials

Nicole Senft, E. Heath, T. Albrecht, 2017, BMC Cancer.